A recurrent chromosome breakpoint in breast cancer at the NRG1/Neuregulin 1/Heregulin gene

Cancer Research

Volumn 64, Issue 19, 2004, Pages 6840-6844

  Huang, Huai En ^a   Chin, Suet Feung ^a   Ginestier, Christophe ^b   Bardou, Valérie Jeanne ^b   Adélaïde, José ^b   Iyer, N Gopalakrishna ^a   Garcia, Maria J ^a   Pole, Jessica C ^a   Callagy, Grace M ^a   Hewitt, Stephen M ^c   Gullick, William J ^d   Jacquemier, Jocelyne ^b   Caldas, Carlos ^a   Chaffanet, Max ^b   Birnbaum, Daniel ^b   Edwards, Paul A W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSERM   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; NEU DIFFERENTIATION FACTOR; PARAFFIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER TISSUE; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE MAPPING; GENE PROBE; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CHROMOSOME BREAKAGE; CHROMOSOME MAPPING; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEUREGULIN-1; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING;

EID: 4944241545     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1762     Document Type: Article

References (20)

1. Adelaide J, Huang HE, Murati A, et al. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Genes Chromosomes Cancer 2003;37:333-45.
2. Richter J. Wagner U. Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000;157:787-94.
3. Ginestier C, Charafe-Jauffret E, Bertucci F, et al. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol 2002;161:1223-33.
4. Courtay-Cahen C, Morris JS, Edwards PA. Chromosome translocations in breast cancer with breakpoints at 8p12. Genomics 2000;66:15-25.
5. Chin SF, Daigo Y, Huang HE, et al. A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumor samples. Mol Pathol 2003;56:275-9.
6. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994;145:1301-8.
7. Fiegler H, Carr P, Douglas EJ, et al. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003;36:361-74.
8. Srinivasan R, Bentort E, McCormick F, Thomas H, Gullick WJ. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer. Clin Cancer Res 1999;5:2877-83.
9. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-through-put molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
10. Raj EH, Skinner A, Mahji TJ, et al. Neuregulin 1-alpha expression in locally advanced breast cancer. Breast 2001;10:41-5.
11. Liu X, Baker E, Eyre HJ, Sutherland GR, Zhou M. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation. Oncogene 1999;18:7110-4.
12. Wang XZ, Jolicoeur EM, Conte N, et al. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line. Oncogene 1999; 18:5718-21.
13. Schaefer G, Fitzpatrick VD, Sliwkowski MX. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene 1997;15:1385-94.
14. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003;284:14-30.
15. Stern DF. ErbBs in mammary development. Exp Cell Res 2003;284:89-98.
16. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988;54:105-15.
17. Bradbury JM, Arno J, Edwards PA. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland. Oncogene 1993;8:1551-8.
18. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2:367-76.
19. Tonon G, Modi S, Wu L, et al. t(11;19)(q21:p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003;33:208-13.
20. Look AT. Oncogenic transcription factors in the human acute leukemias. Science (Wash DC) 1997;278:1059-64.